眼肌型重症肌无力泛化前胸腺切除可获得更高缓解率
倾向性评分匹配后每组65例,泛化前组5年完全稳定缓解累积概率为49.5%(95%CI 0.345-0.611),泛化后组为33.4%(95%CI 0.176-0.462),差异有统计学意义(P=0.0053)。
要点
- 眼肌型重症肌无力泛化前行胸腺切除可能获得更高的完全稳定缓解率。
- 非胸腺瘤亚组结果一致:泛化前组5年缓解率53.5% vs 泛化后组28.9%(P=0.0041)。
- 研究为回顾性设计,需进一步前瞻性验证。
核心结论
- 眼肌型重症肌无力在泛化前行胸腺切除可能比泛化后行胸腺切除获得更高的完全稳定缓解率。
研究设计与样本
- 泛化前手术组(OMG组)73例,泛化后手术组(gOMG组)92例;倾向性评分匹配后每组65例。
主要发现
- 匹配后OMG组5年完全稳定缓解累积概率为49.5%(95%CI 0.345-0.611),gOMG组为33.4%(95%CI 0.176-0.462),P=0.0053。
- 非胸腺瘤亚组(每组55例)中,OMG组5年缓解率为53.5%(95%CI 0.370-0.656),gOMG组为28.9%(95%CI 0.131-0.419),P=0.0041。
临床怎么用
- 对于眼肌型重症肌无力患者,可考虑在泛化前评估胸腺切除的时机,以争取更高的完全稳定缓解概率。
局限性
- 本研究为回顾性设计,可能存在选择偏倚和未测量的混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to compare the outcomes of patients with ocular myasthenia gravis (OMG) who underwent thymectomy before generalization with the outcomes of those who underwent thymectomy after generalization. METHODS: We retrospectively reviewed patients who underwent robotic thymectomy for myasthenia gravis between January 2003 and February 2018. Patients who presented with purely ocular symptoms at myasthenia gravis onset were eligible for inclusion. Exclusion criteria were patients who were lost to follow-up and patients who underwent re-thymectomy. Patients with OMG who developed generalization before thymectomy were categorized into gOMG group and those who did not were categorized into OMG group. The primary outcome was complete stable remission according to the Myasthenia Gravis Foundation of America Post-Intervention Status (MGFA-PIS). RESULTS: One hundred and sixty-five (66 males and 99 females) out of 596 patients with myasthenia gravis were eligible for inclusion. Of these, there were 73 and 92 patients undergoing thymectomy before and after the generalization of OMG, respectively. After propensity score matching, a data set of 130 patients (65 per group) was formed and evaluating results showed no statistical differences between the 2 groups. The estimated cumulative probabilities of complete stable remission at 5 years were 49.5% [95% confidence interval (CI) 0.345-0.611] in the OMG group and 33.4% (95% CI 0.176-0.462) in the gOMG group (P = 0.0053). Similar results were also found in patients with non-thymomatous subgroup [55 patients per group, OMG vs gOMG, 53.5% (95% CI 0.370-0.656) vs 28.9% (95% CI 0.131-0.419), P = 0.0041]. CONCLUSIONS: Thymectomy in OMG before generalization might result in a higher rate of complete stable remission than thymectomy after generalization.
引用
- Li F, Li Z, Chen Y, et al. Thymectomy in ocular myasthenia gravis before generalization results in a higher remission rate. Eur J Cardiothorac Surg. 2020. PMID: 31628812. doi:10.1093/ejcts/ezz275
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。